作为自身免疫性疾病的治疗点的内体细胞收受体
Kensuke Miyake1, Takuma Shibata2, Ryutaro Fukui2
1Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kmiyake@ims.u-tokyo.ac.jp.
Advances in experimental medicine and biology
|March 12, 2024
概括
免疫细胞中的核酸感知托尔类受体 (TLR) 对于病原体防御至关重要. 缺陷的核酸降解导致过度活跃的TLRs,导致自身免疫和自身炎症性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 核酸 (NA) 感应的Toll-like受体 (TLRs) 位于先天免疫细胞的内体内.
- 这些受体识别NA降解产物,启动对病原体的防御反应.
研究的目的:
- 研究NA降解在调节内体TLR反应中的作用.
- 探索受损的NA降解和自身炎症/自身免疫性疾病之间的联系.
主要方法:
- 这项研究的重点是内体内NA降解的机制.
- 它检查了受损的NA降解对TLR信号的后果.
主要成果:
- 对于产生和清除TLR配体而言,NA降解是必不可少的.
- 由于降解受损的NA配体的积累导致构成性TLR激活.
- 这种构成性激活与自身炎症和自身免疫性疾病有关.
结论:
- 内体TLRs是免疫反应的关键调节者.
- 功能障碍的NA降解有助于TLR介导的炎症性疾病.
- 向内体TLRs为这些疾病提供了一个有前途的治疗策略.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Autoimmune Disorders
434
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
434
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cell-mediated Immune Responses
68.3K
Overview
68.3K


